Anagnostis P, Athyros VG, Adamidou F, et al
1g and Supplementary Fig
Lilly PACKAGE LABEL - Mounjaro Single-Dose Vial - 10 mg/0.5 mL Dose NDC 0002-2340-01 Mounjaro (tirzepatide) injection 10 mg/0.5 mL Single-dose Vial - discard unused portion Rx Only For Subcutaneous Use Needles and Syringes are not included Dispense enclosed Medication Guide to each patient
Wear clothing that allows easy access to the injection site, and let the provider know if you have had any prior reactions to injections or supplements
Gastrointestinal adverse effects were most common, including nausea, vomiting, constipation, gastritis, and diarrhea, with higher incidence in Group 1
This process is known as vasodilation